# Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma

> **NCT02137564** · PHASE2 · WITHDRAWN · sponsor: **AIDS Malignancy Consortium**

## Conditions studied

- AIDS-related Kaposi Sarcoma
- HIV Infection
- Recurrent Kaposi Sarcoma

## Interventions

- **DRUG:** gamma secretase inhibitor PF-03084014
- **OTHER:** pharmacological study
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT02137564
- **Lead sponsor:** AIDS Malignancy Consortium
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-07
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Drug supply unavailable
- **Last updated:** 2015-07-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02137564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02137564, "Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02137564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*